Wells Fargo analyst Derek Archila upgraded Immunovant to Overweight from Equal Weight with a price target of $27, up from $10.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMVT:
Wells Fargo analyst Derek Archila upgraded Immunovant to Overweight from Equal Weight with a price target of $27, up from $10.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMVT: